As for the medications for treating SHPH, phosphate binder is the first drug of choice, while vitamin D receptor activator (VDRA) should be reserved for patients with CKD stage 4–5 with severe and progressive SHPT.10 This evidence concerns the gene VDR and chronic kidney disease.